Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 10 2024
0mins
Source: Benzinga
- Skye Bioscience, Inc. SKYE: Skye Bioscience shares fell 18.9% after discontinuing its SBI-100 Ophthalmic Emulsion Phase 2a trial.
- Stock Movements: Various stocks experienced significant price changes during the mid-day session, with some notable gainers and decliners.
- Gainers: Companies like Big Tree Cloud Holdings Limited, KWESST Micro Systems Inc., and Wearable Devices Ltd. saw substantial stock price increases.
- Losers: Several companies, including Sunshine Biopharma, Inc., Enservco Corporation, and Perion Network Ltd., faced notable declines in their share prices.
- Other News: FlexShopper and three other stocks under $5 were highlighted for insider buying activities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
